Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Dynein light chain Tctex-type family member 5 (DYNLT5) is a cytoplasmic protein encoded by the DYNLT5 gene and classified as a light chain component of the cytoplasmic dynein motor protein complex. It is predicted to enable dynein intermediate chain binding activity, to participate in microtubule-based movement, and to form part of the cytoplasmic dynein complex which is essential for intracellular retrograde transport processes[2][4][10][12]. DYNLT5 likely plays a key structural and regulatory role within the dynein complex, facilitating its interaction with specific cargo during organelle and vesicle transport along microtubules[2][4]. Disease associations include primary ciliary dyskinesia subtypes and a potential modifier role in the progression of Duchenne muscular dystrophy[4][10]. There are currently no approved drugs, biomarkers, or safety issues associated with DYNLT5 as a molecular therapeutic target, and it is not currently considered a druggable target[4][10][13].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Dynein light chain Tctex-type family member 5 (DYNLT5).